. Author manuscript; available in PMC: 2013 Sep 1.

Published in final edited form as: J Immunol. 2012 Jul 30;189(5):2478–2487. doi: 10.4049/jimmunol.1103786

Table 2.

HA inhibition by BALF, H-ficolin and pentraxin

Inhibitor	Viral Strain
	Phil82 H3N2	PR-8 H1N1
BALF	2.6±0.86	12±3.7
BALF+Oseltamivir	0.66±0.21^*	2.16±0.41^*
H-Ficolin	1.8±0.16	0.36±0.07
Pentraxin 3	>10	>10
H-Ficolin+Pentraxin	1.09±0^*	0.186±0.04^**

Results are expressed as mean±SEM of 4 experiments in μg/ml of H-ficolin or BALF protein resulting in inhibition of 40 Hemagglutinin units of the indicated strains of IAV. The concentration of oseltamivir added was 10μg/ml. Pentraxin 3 had no independent HA inhibitory activity in this assay up to the maximum concentration tested (i.e., 10 μg/ml). Note that BALF results are expressed as total BALF protein.

indicates where oseltamivir significantly reduced the amount of BALF protein needed to inhibit IAV.

^**

indicates where the effect of the combination of H-ficolin and pentraxin was significantly greater than the effect of either protein alone.